Login / Signup

Associations between calcium channel blocker therapy and mortality in heart failure with preserved ejection fraction.

Xinyi WangJianqing JuZhuo ChenQian LinZihao ZhangQiuyi LiJie ZhangHao XuKeji Chen
Published in: European journal of preventive cardiology (2022)
The use of CCBs was associated with reduced risks of mortality in patients with HFpEF.
Keyphrases
  • cardiovascular events
  • risk factors
  • stem cells
  • human health
  • cardiovascular disease
  • risk assessment
  • coronary artery disease
  • angiotensin ii
  • replacement therapy